Physician
Urology
Dr. Mark K. Plante, MD
|
|
Give Review
Mark K. Plante, MD practices Urology. He has 2 awards "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Mark Plante is a published doctor. He has 26 papers published. The most current publication "The international prostate symptom score: physician versus self-administration in the quantification of symptomatology."
Publications
- Rat animal model for preclinical testing of microparticle urethral bulking agents.
- Ethanol promotes cytotoxic effects of tumor necrosis factor-related apoptosis-inducing ligand through induction of reactive oxygen species in prostate Cancer cells.
- Comparison of intraprostatic ethanol diffusion using a microporous hollow fiber catheter versus a standard needle.
- Safety and feasibility of the prostatic urethral lift: a novel, minimally invasive treatment for lower urinary tract symptoms (LUTS) secondary to benign prostatic hype...
- Retroperitoneoscopic nephrectomy with a modified hand-assisted approach.
- Injectables in the Prostate.
- Minimally invasive therapies for Prostatitis.
- Transurethral ethanol ablation of Prostate.
- Prostatic tissue ablation by injection: a literature review.
- Differential expression of Bladder neurotrophic factor mRNA in male and female rats after Bladder outflow obstruction.
- Family history and the risk of prostatic carcinoma in a high risk group of urological patients.
- Cystic hamartoma of the Renal pelvis: a rare pathologic entity.
- The international Prostate symptom score: physician versus self-administration in the quantification of symptomatology.
- Evaluation of the transurethral ethanol ablation of the Prostate (TEAP) for symptomatic benign prostatic hyperplasia (BPH): a European multi-center evaluation.
- Pheochromocytoma of the urinary Bladder: update on new diagnostic modalities plus case report.
- The Internet and patient education--resources and their reliability: focus on a select urologic topic.
- Re: Ethanol injection therapy of the Prostate for benign prostatic hyperplasia: preliminary report on application of a new technique.
- Transurethral prostatic tissue ablation via a single needle delivery system: initial experience with radio-frequency energy and ethanol.
- Retroperitoneoscopic living donor nephrectomy: initial experience with a unique hand-assisted approach.
- Phase I/II examination of transurethral ethanol ablation of the Prostate for the treatment of symptomatic benign prostatic hyperplasia.
- Ablation of canine Prostate using transurethral intraprostatic absolute ethanol injection.
- Intraprostatic ethanol chemoablation via transurethral and transperineal injection.
- Diffusion properties of transurethral intraprostatic injection.
- Increased expression of neuronal nitric oxide synthase in Bladder afferent cells in the lumbosacral dorsal root ganglia after chronic Bladder outflow obstruction.
- Injection therapy for prostatic Disease: A renaissance concept.
Schools
McGill University Faculty Of Medicine
Procedures Preformed
- AdRenalectomy
- Cystectomy
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Destruction or Excision of Vaginal Lesions
- View All
Conditions Treated
- Bedwetting
- Bladder Cancer
- Bladder Infection
- Bladder Stones
- View All
Doctors Specialties
- Urology
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- EBS-RMSCO
- Fidelis Care HMO
- First Health (Coventry Health Care) PPO
- Medicare Advantage PFFS
- Humana
- Medicaid
- Medicare MCR
- MVP Health Care
- POMCO Group
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
McGill University Faculty of Medicine
Drug Facts
| NPI NUMBER | 1164447520 | |
| NPPES Provider LastName | PLANTE | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 054011473 | |
| NPPES Provider State | VT | |
| Specialty Description | Urology | |
| Total Claim Count | 1028.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164447520 |
| Last Name Of The Provider | PLANTE |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Brian H. Irwin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne L. Viselli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott D. Perrapato, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew C. Mahoney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul M. Morrisseau, MD |
|
|
Dr. Benjamin J. King, MD |
|
|
Dr. A C. Esenler, MD |
|
|
Dr. Gerald C. Mingin Jr., MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Urszula Kowalik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Elizabeth A. Stampfl, PA
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hagop Sarkissian, MD |
|
|
Dr. Jonathan K. Vincent, MD
This Doctor is OpenDoctor Recommended.
|